Here are four recent news updates on gastroenterology and endoscopy companies.
GI & Endoscopy
Daniel C. Chung, MD, is clinical chief of the Gastrointestinal Unit and director of the High-Risk GI Cancer Clinic at Massachusetts General Hospital in Boston. He provides care at the cancer center and digestive healthcare center.
Zacks Investment Research notes that EndoChoice has been assigned a consensus broker rating score of 1.00 — strong buy — from the four brokers that provide coverage for the company, according to a Dakota Financial News report.
Going gluten-free may be trendy and unnecessary for many trying the diet, but this dietary fad has also brought more attention to celiac disease.
Jawad Ahmad, MD, is a gastroenterologist and a professor of medicine and liver diseases at Mount Sinai Hospital in New York. He previously served as the chief of the GI Section at the Veterans Affairs Pittsburgh Healthcare System and was…
Kingsport, Tenn.-based Holston Medical Group added Wanda King, FNP-BC, to HMG Gastroenterology.
One gastroenterologist shares her experience transitioning from various practice settings during her career and offers words of advice for other GI physicians considering a career move.
Essentia Health-Duluth (Minn.) Clinic has added gastroenterologist Ayan Rage, MD, to its team, according to a Duluth News Tribune report.
Clostridium difficile treatment in the outpatient setting often deviates from guidelines, according to a Medscape report.
A positive fecal immunochemical test predicts advanced neoplasia, and requires a colonoscopy for removal. A recent study published in The American Journal of Gastroenterology examines the efficacy of second-look colonoscopies for the assessment of complete removal of AN.
